2021
DOI: 10.1016/j.arres.2021.100016
|View full text |Cite
|
Sign up to set email alerts
|

Sympathoinhibition and vasodilation contribute to the acute hypotensive response of the superoxide dismutase mimic, MnTnBuOE-2-PyP5+, in hypertensive animals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 50 publications
0
1
1
Order By: Relevance
“…The likely mechanism for the association is through the antioxidant enzyme MnSOD, which scavenges reactive oxygen species, such as superoxide anions, that are associated with hypertension. 125 However, we did not observe associations with preeclampsia, which is contrary to the existing literature. Using data from two birth cohorts, Liu et al.…”
Section: Discussioncontrasting
confidence: 99%
“…The likely mechanism for the association is through the antioxidant enzyme MnSOD, which scavenges reactive oxygen species, such as superoxide anions, that are associated with hypertension. 125 However, we did not observe associations with preeclampsia, which is contrary to the existing literature. Using data from two birth cohorts, Liu et al.…”
Section: Discussioncontrasting
confidence: 99%
“…BMX-001 is currently in two Phase II studies—one in combination with radiation therapy and tamazolamide in glioblastoma and high-grade glioma and another in patients with multiple brain metastases (MBM) undergoing whole brain radiation therapy. In addition, the safety and tolerability of BMX-001 are currently being evaluated in two Phase I/II studies using a combination approach of BMX-001, standard radiation therapy (RT), and cisplatin in head and neck cancer patients to reduce radiation-induced mucositis and xerostomia, and in combination with 5-FU in anal squamous cell carcinoma (ASCC) (ClinicalTrials: NCT02655601 , NCT02990468 , NCT03386500 , NCT03608020 ) [ 212 ].…”
Section: Targeting Mitochondria As a Therapeutic Strategymentioning
confidence: 99%